Indivior Pharmaceuticals (INDV) Operating Leases (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Operating Leases of $14.0 million for Q1 2026, down 53.33% year-over-year from $30.0 million in Q1 2025, and down 36.36% quarter-over-quarter from $22.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Operating Leases (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Operating Leases history runs 6 years deep, the most recent figure standing at $14.0 million for Q1 2026.
- In Q1 2026, Operating Leases fell 53.33% year-over-year to $14.0 million; the TTM figure through Mar 2026 stood at $14.0 million (down 53.33% YoY), while the FY2025 annual figure was $22.0 million, down 31.25% from the prior year.
- Operating Leases for Q1 2026 stood at $14.0 million, down from $22.0 million in the prior quarter.
- The five-year high for Operating Leases was $37.0 million in Q4 2022, with the low at $14.0 million in Q1 2026.
- The 5-year median for Operating Leases is $29.5 million (2025), against an average of $27.8 million.
- The sharpest annual moves came in 2022 and 2026: Operating Leases advanced 2.78% in 2022, then tumbled 53.33% in 2026.
- Indivior Pharmaceuticals' Operating Leases stood at $37.0 million in 2022, then decreased by 8.11% to $34.0 million in 2023, then slipped by 5.88% to $32.0 million in 2024, then plunged by 31.25% to $22.0 million in 2025, then sank by 36.36% to $14.0 million in 2026.
- Business Quant data shows INDV's Operating Leases at $14.0 million in Q1 2026, $22.0 million in Q4 2025, and $24.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.53 Bn | 4.31 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Sep 30, 2025 | 24.00 Mn |
| Jun 30, 2025 | 29.00 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Dec 31, 2024 | 32.00 Mn |
| Dec 31, 2023 | 34.00 Mn |
| Dec 31, 2022 | 37.00 Mn |
| Dec 31, 2021 | 36.00 Mn |